Indian E-Pharmacy 1mg Raises $70m, Plans Rapid Scale-up
Executive Summary
India’s largest online pharmacy 1mg has raised $70m in its biggest funding round so far, led by Swiss investor Corisol with backing from the World Bank’s finance arm IFC. The company is planning a “rapid scale-up” with the aim of being the top integrated healthcare services provider in the country by 2023.
You may also be interested in...
Indian Chemists’ Strike Seeks Halt To E-Pharmacy Sales
Pharmacies across India staged a one-day shutdown last week to demand a halt to e-pharmacy sales, becoming the latest retail group to oppose a booming online sector that is seen as threatening earnings of traditional bricks-and-mortar stores in the country.
Top US Court Lifts Discovery Stay On Price-Fixing
The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.
FDA Approves First Generic Of Daraprim
Daraprim, which saw its price jacked up by 4,000% by former drug company executive Martin Shkreli, now has a competitor with the US Food and Drug Administration’s approval of the first generic version of the nearly seven-decade-old drug used to treat a life-threatening parasitic infection known as toxoplasmosis.